Hims & Hers and Ro both offer a path to brand-name Wegovy and Zepbound through the NovoCare and LillyDirect manufacturer programs, and both show up constantly in search results against each other. This comparison covers only that brand-name path — not either company’s history with compounded product — across the categories that actually differ between them: price transparency, clinician access, labs, medication access, cancellation, and support.
Neither platform is a bad choice for the right person. The differences below are mostly about process and structure rather than one being clearly better, and the honest verdict at the end depends heavily on what you personally value in a telehealth relationship.
This guide provides general information and is not medical advice. Talk to your prescriber or pharmacist before starting, stopping, or changing any medication, supplement, or device used alongside GLP-1 therapy.
Price Transparency and What You See Before Paying
Ro leans into lab inclusion and a bundled membership price shown early in its flow, which makes the total easier to estimate before you commit to an intake. Check Ro’s current pricing directly, since membership tiers change. Disclosure: this is an affiliate link. GLP-1 Explained may earn a commission if you buy or sign up, at no extra cost to you. This is not medical advice.
Hims & Hers’ intake is faster to start, but the full monthly total — membership plus the brand-name drug cost through NovoCare or LillyDirect — is less visible until further into the flow. See Hims & Hers’ current plans and ask for the combined total in writing before your first charge, regardless of which platform you use.
Clinician Access, Labs, and Medication Access
Ro’s model is built around ongoing prescriber access as part of the membership, with labs included or coordinated through a partner rather than left to you to arrange. That structure suits someone who wants fewer separate errands and does not mind a somewhat higher visible membership price for that convenience.
Hims & Hers relies more on asynchronous messaging between visits rather than a standing relationship with a single named clinician, and its lab requirements can mean submitting your own recent results or using a local partner depending on your state. On medication access specifically, both platforms state that a qualifying patient is prescribed brand-name Wegovy or Zepbound rather than a compounded formulation — but Hims & Hers’ consumer brand has also marketed compounded semaglutide and tirzepatide in the past and received an FDA warning letter about that marketing in September 2025, which makes it worth confirming the brand-name path explicitly during your own intake rather than assuming it from the platform’s general marketing.
Cancellation and Support
Both platforms run on auto-renewing memberships, and neither makes cancellation as prominent as signup. Read the cancellation terms during intake, not after you have decided to stop — the process on both is typically self-service through account settings, but the exact notice period and refund handling for a partial month varies and is worth confirming directly since terms change.
Support quality on both is generally messaging-based rather than phone-based for routine questions, which is faster for simple issues and more frustrating for anything that needs a real conversation, such as a side effect you are unsure about. If you know you want to talk to a person on the phone when something goes wrong, ask about that option before you sign up rather than discovering the answer during a bad week.
What to Look For
The combined monthly total, not the advertised starting price. Membership fee plus brand-name drug cost together, confirmed before your first charge.
Confirmation that your prescription is brand-name, not compounded. Ask this directly during intake on either platform rather than inferring it from marketing copy.
A cancellation process you have actually read, not just assumed. Both are auto-renewing memberships; know the notice period before you need it.
A support channel that matches how you actually want to reach someone. If phone support matters to you for anything beyond routine questions, confirm it exists before signing up.
Useful Extras Worth Owning
These cover the realistic range of what actually helps, from the one item worth buying first to the small extra that makes the rest of the list easier to use.
A baseline reading you bring to either platform’s intake, rather than one generated by whichever company you end up choosing.
View on Amazon →Independent, platform-agnostic data on your own trend over the first few months, useful regardless of which company is managing your prescription.
View on Amazon →Needed the moment either platform’s pharmacy partner ships your first prescription, so it is worth having before that day arrives.
View on Amazon →Protects a NovoCare or LillyDirect shipment in transit and on any trip afterward, regardless of which of the two platforms sent it.
View on Amazon →Hims & Hers vs Ro, Category by Category
| Category | Hims & Hers | Ro |
|---|---|---|
| Price transparency | Full total less visible until later in the flow | Bundled price shown earlier in the flow |
| Clinician access | Mostly asynchronous messaging between visits | Ongoing prescriber access built into membership |
| Labs | Submit your own or use a local partner, varies by state | Included or coordinated through a partner lab |
| Medication access | Brand-name via NovoCare/LillyDirect — confirm at intake | Brand-name via Novo Nordisk partnership |
| Cancellation | Self-service; confirm notice period directly | Self-service; confirm notice period directly |
| Support | Messaging-based for routine questions | Messaging-based, tied to membership structure |
The Honest Verdict, by Reader Type
If you already have recent labs or do not mind arranging your own, want the fastest possible intake, and are comfortable with asynchronous messaging instead of a standing relationship with one clinician, Hims & Hers’ model fits better. If you would rather see labs and an ongoing prescriber relationship bundled into one membership price up front, and you are willing to pay for that convenience, Ro is the better structural fit.
Neither difference is large enough to make the “wrong” choice dangerous — both route qualifying patients to the same brand-name medications through the same manufacturer programs. The decision comes down to how you want the surrounding service to work, not which one gets you a better drug. Neither is a fit for anyone who is pregnant or breastfeeding, has a personal or family history of medullary thyroid carcinoma or MEN2, or has a history of pancreatitis — that combination calls for an in-person physician, not either telehealth flow.
Three Things This Comparison Doesn’t Cover
Product roundups answer which one. They do not answer the questions that come up regardless of which products you choose:
- The full cost and insurance picture — how self-pay compares to an insurance-covered path with a manufacturer savings card.
- Which drug you actually want — why Wegovy and Ozempic share a molecule but not a price tag or indication.
- What happens after either platform ships your first dose — the side-effect timeline that is the same regardless of which company wrote the prescription.